# Biovie Inc.: filings

BIVI · Nasdaq · CIK 1580149 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/bivi.md) · [Financials](/companies/bivi/financials.md) · [Filings](/companies/bivi/filings.md) · [Insiders](/companies/bivi/insiders.md)

## Reports and events: 203 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 113, 8-K 88, 10-Q 39, CORRESP 28, S-1/A 25, UPLOAD 20, 3 19, 424B5 18, 10-K 13, 5 13, EFFECT 11, SC 13D/A 10, DEF 14A 9, 424B3 7, 8-K/A 7, S-1 7, D 6, PRE 14C 5, CERT 4, FWP 4, NT 10-Q 4, PRE 14A 4, S-3 4, 144 3, 8-A12B 3, DEF 14C 3, RW 3, S-8 3, DRS 2, NT 10-K 2, POS AM 2, SCHEDULE 13G 2, 10-K/A 1, 10-Q/A 1, 1-A 1, 424B4 1, 8-A12B/A 1, 8-A12G 1, AW 1, DEFA14A 1, DEFM14C 1, DRSLTR 1, POS EX 1, PREM14C 1, PRER14A 1, PRER14C 1, RW WD 1, S-1MEF 1, SC 13D 1, SC 13G 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 17:13 ET | [DEF 14A](/filings/0001520138-26-000395.md) | Proxy statement, period 2026-09-28 | 0001520138-26-000395 |
| 2026-09-14 | 18:16 ET | [8-K](/filings/0001520138-26-000391.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001520138-26-000391 |
| 2026-08-14 | 17:23 ET | [S-1/A](/filings/0001520138-26-000350.md) | Registration statement, amended | 0001520138-26-000350 |
| 2026-08-13 | 19:36 ET | [10-K](/filings/0001520138-26-000332.md) | Annual report, period 2026-06-30 | 0001520138-26-000332 |
| 2026-08-06 | 07:41 ET | [S-1/A](/filings/0001520138-26-000313.md) | Registration statement, amended | 0001520138-26-000313 |
| 2026-08-06 | 07:35 ET | [8-K](/filings/0001520138-26-000312.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-26-000312 |
| 2026-07-31 | 17:29 ET | [S-1/A](/filings/0001520138-26-000299.md) | Registration statement, amended | 0001520138-26-000299 |
| 2026-07-17 | 17:21 ET | [S-1](/filings/0001520138-26-000276.md) | Registration statement | 0001520138-26-000276 |
| 2026-05-11 | 16:56 ET | [10-Q](/filings/0001520138-26-000154.md) | Quarterly report, period 2026-03-31 | 0001520138-26-000154 |
| 2026-03-25 | 17:00 ET | [SCHEDULE 13D](/filings/0001520138-26-000086.md) | Ownership report, active investor | 0001520138-26-000086 |
| 2026-02-06 | 17:01 ET | [10-Q](/filings/0001520138-26-000052.md) | Quarterly report, period 2025-12-31 | 0001520138-26-000052 |
| 2025-11-13 | 17:01 ET | [8-K](/filings/0001520138-25-000352.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001520138-25-000352 |
| 2025-11-12 | 17:06 ET | [8-K](/filings/0001520138-25-000347.md) | 5.07 Shareholder vote results | 0001520138-25-000347 |
| 2025-11-10 | 17:01 ET | [10-Q](/filings/0001520138-25-000343.md) | Quarterly report, period 2025-09-30 | 0001520138-25-000343 |
| 2025-09-25 | 17:26 ET | [DEF 14A](/filings/0001520138-25-000287.md) | Proxy statement, period 2025-09-25 | 0001520138-25-000287 |
| 2025-08-15 | 17:05 ET | [10-K](/filings/0001520138-25-000268.md) | Annual report, period 2025-06-30 | 0001520138-25-000268 |
| 2025-08-11 | 16:25 ET | [8-K](/filings/0001520138-25-000249.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-25-000249 |
| 2025-08-04 | 08:52 ET | [S-1/A](/filings/0001520138-25-000235.md) | Registration statement, amended | 0001520138-25-000235 |
| 2025-07-23 | 16:49 ET | [8-K](/filings/0001520138-25-000223.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-25-000223 |
| 2025-07-22 | 08:31 ET | [S-1/A](/filings/0001520138-25-000216.md) | Registration statement, amended | 0001520138-25-000216 |
| 2025-07-11 | 17:19 ET | [S-1/A](/filings/0001520138-25-000205.md) | Registration statement, amended | 0001520138-25-000205 |
| 2025-07-03 | 17:01 ET | [S-1](/filings/0001520138-25-000198.md) | Registration statement | 0001520138-25-000198 |
| 2025-06-30 | 20:35 ET | [SCHEDULE 13D/A](/filings/0001104659-25-064301.md) | Ownership report, active investor, amended | 0001104659-25-064301 |
| 2025-06-27 | 17:20 ET | [8-K](/filings/0001520138-25-000190.md) | 3.03 Change to security holders’ rights | 0001520138-25-000190 |
| 2025-06-24 | 17:20 ET | [8-K](/filings/0001520138-25-000185.md) | 5.07 Shareholder vote results | 0001520138-25-000185 |
| 2025-06-02 | 16:16 ET | [DEF 14A](/filings/0001520138-25-000166.md) | Proxy statement, period 2025-06-02 | 0001520138-25-000166 |
| 2025-05-12 | 17:15 ET | [10-Q](/filings/0001520138-25-000144.md) | Quarterly report, period 2025-03-31 | 0001520138-25-000144 |
| 2025-03-28 | 17:00 ET | [8-K](/filings/0001520138-25-000089.md) | 5.02 Departure or appointment of officers or directors | 0001520138-25-000089 |
| 2025-02-11 | 17:00 ET | [10-Q](/filings/0001520138-25-000056.md) | Quarterly report, period 2024-12-31 | 0001520138-25-000056 |
| 2024-11-27 | 15:16 ET | [S-1/A](/filings/0001520138-24-000434.md) | Registration statement, amended | 0001520138-24-000434 |
| 2024-11-21 | 17:29 ET | [S-1](/filings/0001520138-24-000429.md) | Registration statement | 0001520138-24-000429 |
| 2024-11-13 | 16:46 ET | [10-Q](/filings/0001520138-24-000425.md) | Quarterly report, period 2024-09-30 | 0001520138-24-000425 |
| 2024-11-08 | 17:15 ET | [8-K](/filings/0001520138-24-000410.md) | 5.07 Shareholder vote results | 0001520138-24-000410 |
| 2024-10-29 | 16:15 ET | [8-K](/filings/0001520138-24-000404.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001520138-24-000404 |
| 2024-10-29 | 06:00 ET | [8-K](/filings/0001520138-24-000400.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-24-000400 |
| 2024-10-24 | 16:15 ET | [8-K](/filings/0001520138-24-000387.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001520138-24-000387 |
| 2024-10-24 | 09:15 ET | [8-K](/filings/0001520138-24-000379.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-24-000379 |
| 2024-10-22 | 16:01 ET | [8-K](/filings/0001520138-24-000376.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001520138-24-000376 |
| 2024-10-22 | 08:48 ET | [8-K](/filings/0001520138-24-000372.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-24-000372 |
| 2024-09-30 | 17:08 ET | [10-K](/filings/0001520138-24-000324.md) | Annual report, period 2024-06-30 | 0001520138-24-000324 |
| 2024-09-27 | 17:00 ET | [DEF 14A](/filings/0001520138-24-000322.md) | Proxy statement, period 2024-09-27 | 0001520138-24-000322 |
| 2024-09-25 | 17:02 ET | [8-K](/filings/0001520138-24-000320.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001520138-24-000320 |
| 2024-09-24 | 16:46 ET | [8-K/A](/filings/0001520138-24-000313.md) | 9.01 Financial statements and exhibits | 0001520138-24-000313 |
| 2024-09-24 | 09:20 ET | [8-K](/filings/0001520138-24-000310.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-24-000310 |
| 2024-08-21 | 21:31 ET | [8-K](/filings/0001520138-24-000282.md) | 8.01 Other events | 0001520138-24-000282 |
| 2024-08-06 | 06:00 ET | [8-K/A](/filings/0001520138-24-000263.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001520138-24-000263 |
| 2024-08-01 | 16:41 ET | [8-K](/filings/0001520138-24-000254.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001520138-24-000254 |
| 2024-07-30 | 17:15 ET | [8-K](/filings/0001520138-24-000251.md) | 5.02 Departure or appointment of officers or directors | 0001520138-24-000251 |
| 2024-06-25 | 19:47 ET | [SC 13D/A](/filings/0001104659-24-074862.md) | Ownership report, active investor, amended | 0001104659-24-074862 |
| 2024-06-17 | 17:05 ET | [DEF 14A](/filings/0001520138-24-000228.md) | Proxy statement, period 2024-06-17 | 0001520138-24-000228 |

Page 1 of 5. [Older](/companies/bivi/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.